Funding for this research was provided by:
National Center for Advancing Translational Sciences (CTSA; 5 UL1 RR025774, U01HG006476, U54GM114833)
National Human Genome Research Institute (HG010881)
Received: 23 March 2020
Accepted: 9 November 2020
First Online: 23 November 2020
Ethics approval and consent to participate
: Data was downloaded from dbGAP under a Scripps Institutional Review Board protocol IRB-17-7005. Informed consent was obtained by the original ARIC study investigators. This research conforms with the principles of the Helsinki Declaration.
: Individuals were consented for publication under the original ARIC study protocols.
: AT declares he is co-founder of geneXwell. The remaining authors declare that they have no competing interests.